Results 71 to 80 of about 42,568 (290)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub +24 more
wiley +1 more source
Coalition structures induced by the strength of a graph [PDF]
We study cooperative games associated with a communication structure which takes into account a level of communication between players. Let us consider an undirected communication graph : each node represents a player and there is an edge between two ...
Michel Grabisch, Alexandre Skoda
core
Improving Attack Graph Visualization through Data Reduction and Attack Grouping [PDF]
, 2008 Various tools exist to analyze enterprise network systems and to produce attack graphs detailing how attackers might penetrate into the system. These attack graphs, however, are often complex and difficult to comprehend fully, and a human user may find ...
Homer, John +3 more
core
Study of SDN intrusion intent identification algorithm based on Bayesian attack graph
Tongxin xuebao, 2023 Since the existing software defined network (SDN) security prediction methods do not consider the attack cost and the impact of controller vulnerabilities on SDN security, a Bayesian attack graph-based algorithm to assessing SDN intrusion intent was ...
Zhiyong LUO +3 more
doaj +2 more sources
Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti‐LGI1 Encephalitis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Anti–leucine‐rich glioma‐inactivated 1 encephalitis (LGI1‐E) can cause persistent cognitive deficits, but the mechanisms remain unclear. A 40‐year‐old woman with LGI1‐E presented with subacute cognitive deficits and showed mild left medial temporal lobe (MTL) swelling and fluid‐attenuated inversion recovery (FLAIR) hyperintensity on initial ...
Yusuke Akitomi +8 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To characterize the demographic, clinical, and laboratory features of the Chinese patients of genetic Creutzfeldt‐Jakob disease with T188K variant (T188K‐gCJD), the most common subtype of genetic prion diseases (gPrDs) in China. Methods In this nationwide retrospective study, data from 98 genetically confirmed T188K‐gCJD patients ...
Chun‐Jie Li +11 more
wiley +1 more source
Graph Structural Attack by Perturbing Spectral Distance
, 2022 Graph Convolutional Networks (GCNs) have fueled a surge of research interest due to their encouraging performance on graph learning tasks, but they are also shown vulnerability to adversarial attacks.
Lin, Lu, Wang, Hongning, Blaser, Ethan
core
Heterogeneous Graph Backdoor Attack
CoRRHeterogeneous Graph Neural Networks (HGNNs) excel in modeling complex, multi-typed relationships across diverse domains, yet their vulnerability to backdoor attacks remains unexplored. To address this gap, we conduct the first investigation into the susceptibility of HGNNs to existing graph backdoor attacks, revealing three critical issues: (1) high ...
Jiawei Chen +4 more
openaire +2 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw +5 more
wiley +1 more source